Y-mAbs splits from commercial chief, tasks new hire with growing cancer drug sales

13th January 2025 Uncategorised 0

Y-mAbs Therapeutics is parting ways with its chief commercial officer and putting a new hire in charge of the cancer drug Danyelza. The biotech made the changes, which include “a small adjustment” to the commercial team, as part of a rethink that could put 13% of its employees out of work.

More: Y-mAbs splits from commercial chief, tasks new hire with growing cancer drug sales
Source: fierce